Quick Answer
Revolution Medicines, Inc. reported Common Stock Shares Outstanding of 197.00 million shares for the year ending 2025.
- Revolution Medicines, Inc. showed an increase of +6.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Revolution Medicines, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Revolution Medicines, Inc.'s Common Stock Shares Outstanding has grown by 5,884.0%.
- Historical annual values: Fiscal year 2025: 197.00 million shares | Fiscal year 2024: 185.90 million shares | Fiscal year 2023: 164.67 million shares | Fiscal year 2022: 90.41 million shares | Fiscal year 2021: 74.14 million shares | Fiscal year 2020: 66.60 million shares | Fiscal year 2019: 3.29 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: